Probiotic-derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation. Jiang M, Li F, Liu Y, Gu Z, et al. Hepatology 2023;77:1164-1180.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jiang M, Li F, Liu Y, Gu Z, et al. Probiotic-derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation. Hepatology 2023;77:1164-1180.
PMID: 35689610